# The CU Healthcare Innovation Fund

Investor in Denver, Colorado

## About The CU Healthcare Innovation Fund

The CU Healthcare Innovation Fund is a $50 million strategic healthcare-focused venture capital fund affiliated with the CU Anschutz Medical Campus. The fund invests in early-stage and growth-stage digital health, software-enabled service companies, and pharmaceutical, medical device, and diagnostic companies whose technology is derived from CU Anschutz intellectual property.

The fund's mission is to support the development and commercialization of innovative healthcare technologies that improve patient care and reduce costs. The fund team has deep experience in healthcare investing and operations and provides its portfolio companies with access to the CU Anschutz Medical Campus's world-class faculty, researchers, and clinicians.

The CU Healthcare Innovation Fund is a valuable resource for healthcare startups, providing them with the capital and expertise they need to succeed. The fund has a strong track record of success, having invested in companies that have gone on to raise significant capital and be acquired by leading healthcare companies.

## People

- **Steven Lindseth**, General Partner

## Key Facts

- **Location:** Denver, Colorado
- **Investor Type:** Venture Capital
- **Founded:** 2019

## Investment Industries

- Biotech
- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/the-cu-healthcare-innovation-fund
- More investors: [Biotech Investors in Colorado](https://askforfunding.com/site/angel-investors/colorado/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
